SCHEMBL30452092

SCHEMBL30452092

NCCc1ccc(-c2ccccn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 1/20 0.50
HTR2A P28223 2/20 0.48
LOXL2 Q9Y4K0 2/20 0.48
CYP2A6 P11509 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 1/20 0.47
CYP19A1 P11511 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MAOB P27338 4/20 0.47
HCAR2 Q8TDS4 1/20 0.47
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4423669 1.00 HRH1 (0.50) HRH1HTR2ALOXL2CYP2A6SMN1; SMN2
SCHEMBL27706642 0.87 ADRB2 (0.60) LOXL2CYP2A6SMN1; SMN2TAAR1CA12
SCHEMBL30083578 0.85 ADRB2 (0.62) LOXL2CYP2A6SMN1; SMN2TAAR1CA12
SCHEMBL505581 0.85 ADRB2 (0.62) LOXL2CYP2A6SMN1; SMN2TAAR1CA12
SCHEMBL2344310 0.84 CYP1A2 (0.58) CYP2A6SMN1; SMN2CA12CA1CA2
SCHEMBL14268241 0.83 BRS3 (0.50) CYP2A6SMN1; SMN2CA12CA1CA2
Ammonia Solution, Strong SCHEMBL3722160 0.83 ADRB2 (0.60) LOXL2CYP2A6SMN1; SMN2TAAR1CA12
Hydrochloric Acid SCHEMBL31682452 0.83 ADRB2 (0.60) LOXL2CYP2A6SMN1; SMN2TAAR1CA12
SCHEMBL1138773 0.81 HCAR2 (0.50) CYP2A6CA12CA1CA2CA9
SCHEMBL1129824 0.81 CYP1A2 (0.47) CYP2A6SMN1; SMN2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111164084-B Triazolotriazine derivatives useful as A2A receptor antagonists 浙江春禾医药科技有限公司 2023-05-23 CN disclosed